Recent advances in therapeutics delivery, including the advent of cellular therapies and rising popularity of biosimilars, have introduced new challenges for drug developers and regulatory bodies alike. At Charles River, we immerse ourselves in niche markets, stay abreast of regulatory changes and keep up with new technologies so we can support the specific testing and manufacturing requirements of all product types.